Table 2.
Demographic characteristics.
| Adjuvanted HAI-05 | Unadjuvanted HAI-05 | Placebo | ||||
|---|---|---|---|---|---|---|
| 15 µg | 45 µg | 90 µg | 90 µg | |||
| N = 18 | N = 20 | N = 20 | N = 20 | N = 22 | ||
| Female, n (%) | 13 (72.2) | 11 (55.0) | 12 (60.0) | 12 (60.0) | 11 (50.0) | |
| Age (years) | ||||||
| n | 18 | 20 | 20 | 20 | 22 | |
| Mean | 31.8 | 31.1 | 32.0 | 30.1 | 34.1 | |
| SD | 8.3 | 9.2 | 9.6 | 7.8 | 9.5 | |
| Median | 30.0 | 30.5 | 29.5 | 28.5 | 32.0 | |
| (Min, Max) | (18, 46) | (18, 49) | (19, 47) | (18, 42) | (21, 49) | |
| Race, n (%) | ||||||
| White | 15 (83.3) | 17 (85.0) | 13 (65.0) | 14 (70.0) | 19 (86.4) | |
| Black or African American | 3 (16.7) | 3 (15.0) | 7 (35.0) | 6 (30.0) | 2 (9.1) | |
| Asian | 0 | 0 | 0 | 0 | 1 (4.5) | |